Akira Homma

Manguinhos, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines.

Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines.

Journal: Frontiers in public health

Published: April 17, 2025

Immunogenicity, safety and immunological memory of a Brazilian meningococcal C conjugate vaccine on a phase II clinical trial.

Immunogenicity, safety and immunological memory of a Brazilian meningococcal C conjugate vaccine on a phase II clinical trial.

Journal: Vaccine

Published: January 23, 2025

Reply to the Letter to the Editors by Beirão.

Reply to the Letter to the Editors by Beirão.

Journal: Cadernos de saude publica

Published: April 24, 2024

Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study.

Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study.

Journal: Vaccine

Published: April 15, 2024

For the return of high vaccination coverage

For the return of high vaccination coverage

Journal: Cadernos de saude publica

Published: December 19, 2022

Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.

Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.

Journal: Vaccine

Published: September 16, 2021

Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.

Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.

Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Published: July 12, 2021

Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice.

Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice.

Journal: Lancet regional health. Americas

Published: June 09, 2021

COVID-19 and Future Disease X in Circular Economy Transition: Redesigning Pandemic Preparedness to Prevent a Global Disaster.

COVID-19 and Future Disease X in Circular Economy Transition: Redesigning Pandemic Preparedness to Prevent a Global Disaster.

Journal: Circular economy and sustainability

Published: March 01, 2021

Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era.

Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era.

Journal: Circular economy and sustainability

Published: March 01, 2021

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.

Journal: The Journal of experimental medicine

Published: November 20, 2020

Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.

Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.

Journal: Vaccine

Published: February 03, 2020

Showing 1-12 of 41

Last Updated: 09/26/2026